Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.
A jury unanimously found that Axonics did not infringe any of the three patents-in-suit brought against the company by Medtronic in a patent infringement lawsuit in the U.S. District Court for the ...
The latest example of her drive, dedication and whitetail savvy is her jaw-dropping 2023 Illinois bow buck — a long-tined main-frame 10-pointer the hard-hunting 26-year-old called into bow range last ...